 TMEV VP1 localises to the perinuclear region and cytoplasm of infected cells  TMEV VP1 and Hsp90 colocalise in the perinuclear region and cytoplasm  TMEV VP1 did not localise to the nucleus during infection  A typical NLS was absent from the TMEV VP1 sequence  TMEV VP1 localises in a similar manner to FMDV and EV71 VP1
Introduction
Picornaviruses are a diverse family of small non-enveloped RNA viruses that includes various pathogens of significant clinical and economic importance. Notable human pathogens include poliovirus (PV), human rhinovirus (HRV), Coxsackievirus A and B (CVA; CVB), enterovirus 71 (EV71) and hepatitis A virus (HAV) (Hagan et al., 2015; Rotbart and Hayden, 2000) . Animal pathogens of high economic importance include foot-and-mouth disease virus (FMDV) and swine vesicular disease virus (SVDV) (Brito et al., 2015; Mansour et al., 2015) .
The picornavirus capsid is a non-enveloped icosahedral capsid with pseudo-T = 3 symmetry and is approximately 30 nm in diameter. The capsid consists of 60 capsomers each of which contains three subunits, namely VP1, VP2 and VP3. A fourth capsid protein, VP4, is found on the internal side of the capsid (Bedard and Semler, 2004) . Picornavirus capsids exemplify macromolecule assembly through the consecutive oligomerisation of different protein complexes ( Fig. 1) . Following the cleavage of the precursor P1, the subunits assemble into protomer structures, each comprising a single copy of the VP0, VP1 and VP3 subunits. The pentamer structures are subsequently formed through the interaction of five protomer structures. Formation of 80S empty procapsids then occurs following the assembly of 12 pentamer structures. Alternatively 12 pentamers assemble around the mRNA genome to constitute the 150S provirion, and cleavage of the VP0 precursor yields mature infectious virus particles (Jiang et al., 2014) .
The most external and accessible surface protein of the capsid is VP1. The general structure of the protein is wedge shaped and consists of eight stranded β-barrels, with connecting loops between the barrels and the N and C termini of the protein (Rueckert, 1996) . VP1 has been reported to play a role in host cell attachment, and is considered the most immunodominant of the four capsid proteins (Edlmayr et al., 2011; Meloen Briaire et al., 1983; Rossmann et al., 1985) . There have been several investigations into the identification of immunogenic regions within this protein. In FMDV, the VP1 capsid protein has been reported to contain the highest number of neutralisation sites, particularly within the βG-βH loop region (Collen et al., 1991) . Varrasso et al., (2001) identified neutralisation sites located within the N and C termini as well as the βE-βF and βG-βH loops of Equine Rhinitis Virus (ERAV) VP1, with strong antibody recognition against the N-terminus. Similarly, major VP1 neutralisation sites have been reported for TMEV (Cameron et al., 2001; Luo et al., 1992) and the enteroviruses (Mateu, 1995; Oberste et al., 1999; Wu et al., 2001 ) with key neutralising determinants located in the N-terminal region of VP1 (Bobek et al., 2010; Tan and Cardosa, 2007) .
Since picornavirus genomes have limited coding capacity, these viruses are dependent on a range of host cellular proteins and pathways to mediate viral entry, replication and assembly.
While it has been established that pentamers self-assemble into intact empty capsids in vitro in a process mediated by protein-protein interactions with no apparent requirement for other viral or cellular factors (Li et al., 2012; Rombaut et al., 1991) , the steps between P1 to pentamer assembly are complex, and appear to involve multiple viral and cellular components. Significantly, it has been established that chaperones in the heat shock protein family, for example Hsp90 and Hsp70, are crucial for enterovirus replication as indicated by an association of these chaperones with the capsid P1 precursor (Geller et al., 2007; Macejak and Sarnow, 1992) . While strong evidence links the involvement of Hsp90 in P1 processing, it has also been reported that Hsp90 promotes the formation of pentamers from 5S protomers during FMDV infection (as reviewed by Jiang et al., 2014) .
To date, most studies investigating picornavirus replication and assembly have been carried out using picornaviruses such as PV, HAV and FMDV. Very few describe the localisation of picornavirus capsid subunits in cells at the early stages of virus assembly, which remains a poorly understood process in the virus life cycle. Theiler's murine encephalomyelitis virus (TMEV) is a naturally occurring murine Cardiovirus infecting the central nervous system of mice causing demyelination (Lipton, 1975) . Several strains of the virus have been identified with the GDVII and FA strains being highly neurovirulent and causing acute fatal encephalitis in mice. The BeAn and DA strains are less virulent inducing a chronic demyelinating condition, and these have been extensively studied as a model for investigating the pathogenesis of multiple sclerosis (reviewed by Oleszak et al., 2004) . Furthermore, the capsid structure of the TMEV DA strain has been determined at atomic resolution using Xray crystallography providing a template on which other strains can be modelled (Grant et al., 1992) . Our previous studies have reported that the TMEV GDVII 2C protein localises to the Golgi apparatus and endoplasmic reticulum (ER) both during infection, and when expressed alone in cells (Jauka et al., 2010; Murray et al., 2009 ). In addition, we have reported that TMEV infection results in a redistribution of Hsp90 into the replication complex where it overlaps with viral replication protein 2C, and that inhibition of Hsp90 by geldanamycin and novobiocin supresses the cytopathic effect of the virus suggesting an important role for this protein in the virus life cycle (Mutsvunguma et al., 2011) . To extend these studies and further investigate virus-host interactions during infection, we used a bioinformatics approach to analyse the nucleotide sequence of the VP1 capsid subunit and predict a potential antigenic region. The peptide consisting of amino acids 1-112 in frame with a 6x histidine tag was successfully expressed in Escherichia coli cells, solubilised in the presence of NLauroylsarcosine and purified for subsequent immunisation of rabbits. The antibodies were used to investigate the localisation of VP1 at 5 hours post infection (hpi) and determine the distribution of VP1 relative to Hsp90.
Materials and Methods

Homology modelling of the TMEV GDVII protomer complex
Sequence retrieval, alignment and template selection
The protein sequences, corresponding to the four subunits of the TMEV GDVII protomer were retrieved from the GenBank database (NCBI VP1-VP4: NP_740427.1, NP_740425.1, NP_740426.1, NP_740424.1) in FASTA format. The sequences were individually submitted to HHpred (Soding et al., 2005) for the identification of homologous protein structures for each subunit. As the study aimed to model the full TMEV GDVII protomer complex, only full protomer structures which contained template chains for all four protomer subunits were selected as possible templates. Initially, ten structures were selected as possible templates (supplementary table S1 ). The structural alignment program PROMALS3D (Pei et al., 2008) was then used to align the target sequences of each respective GDVII protomer subunit to ten structural sequences corresponding to the subunits of selected protomer templates. To ensure that the subunit-subunit interfaces were modelled correctly, each protomer template was submitted to the Protein Interactions Calculator (PIC) (Tina et al., 2007) for the identification of residues involved in inter-protein interactions. As each of the four subunits interacts with three other subunits, a total of 12 interfaces were examined. The interacting residues, predicted for each subunit-subunit interface, were then mapped to the respective multiple sequence alignments using in-house scripting. To assess the conservation of interface residues against the target sequences, the resulting alignments were visualised in Jalview (Waterhouse et al., 2009 ). An example of this analysis is shown for the VP1 subunit in supplementary Fig. S1 . Subsequent to the observation that predicted interacting residues were highly conserved across the ten structures the final template selection was based on the following criteria: i) highest average sequence identity to the target protomer as calculated across all four subunit proteins, ii) template resolution and iii) the sequence identity to the VP1 subunit (supplementary table S1). The crystal structures of TMEV DA (PDB ID: 1TME) and HEV-D68 (PDB ID: 4WM8) were selected as templates for the modelling of the TMEV GDVII protomer (supplementary table S2).
Model building and validation
Homology models of the full TMEV GDVII protomer complex were calculated using MODELLER 9v15 (Sali and Blundell, 1993) , set to generate 100 unique models through very slow refinement. Given that the TMEV DA structure (PDB ID: 1TME) had high sequence identity to the target; an initial model set based only on this template was constructed. In an attempt to improve the quality of the models, a second model set based on a combination of TMEV DA with the higher resolution structure of HEV-D68 (PDB ID: 4WM8) was constructed. The models were initially evaluated according to the normalized DOPE-Z score (supplementary table S3). To validate the models' subunit interfaces the three best scoring models from each set were submitted to PIC followed by the mapping of predicted interacting residues to multiple sequence alignments. The models were also visualised in PyMOL (Schrodinger, 2010) for the identification of any geometric discrepancies. The top scoring model was additionally evaluated using PROSA (Wiederstein and Sippl, 2007) .
Prediction of linear epitope regions on the surface of TMEV GDVII VP1
Linear epitope regions within TMEV GDVII VP1 were predicted using the webservers EliPro (Ponomarenko et al., 2008) and BepiPred (Larsen et al., 2006) . The predicted VP1 epitopes were mapped to the homology model of the TMEV GDVII protomer to validate surface accessibility of these regions when the VP1 subunit is in an assembled protomer complex.
The mapping and structural analysis was performed in PyMOL (Schrodinger, 2010) . To investigate the epitope regions which were more likely to be soluble the GDVII VP1 sequence was submitted to Protscale (Gasteiger et al., 2005) for the prediction of hydrophobic and hydrophilic regions based on the Kyte and Doolittle method (Kyte and Doolittle, 1982) .
Prediction of nuclear localisation signals and multiple sequence alignment of the Cterminus of VP1
The VP1 sequences of TMEV GDVII (NCBI: NP_740427), CVB3 (GenBank accession: U57056), EV71 (GenBank accession: HQ882182) and FMDV (GenBank accession: CAA00045) were retrieved from the GenBank database. The sequences were individually submitted to NucPred (Brameier et al., 2007) and SeqNLS (Lin and Hu, 2013) for the prediction of a nuclear localisation site. For identification of amino acid mutations the sequences were aligned using Promals3D (Pei et al., 2008) and visualised in Jalview (Waterhouse et al., 2009 ).
Plasmids
TMEV VP1 (1-112) was expressed in the E. coli strain JM109 from plasmid pCRTVP1. To create this plasmid, nucleotides 1-336 of the TMEV VP1 coding sequence were PCRamplified from the TMEV GDVII cDNA, using the KAPA Taq ReadyMix kit (KAPA Biosystems, Cape Town, South Africa) and gene-specific oligonucleotide primers. The PCR product was ligated into plasmid pQE-80L (Qiagen, Mannheim, Germany) by restriction with BamHI and SalI. To confirm the presence of the insert and correct open reading frame, plasmid pCRTVP1 was sequenced by Inqaba Biotechnical Industries (Pty) Ltd., Pretoria South Africa.
Protein expression, SDS-PAGE and Western blotting
E. coli cells transformed with pCRTVP1 and pQE-80L were cultured in Luria broth (LB) supplemented with 100 µg/ml ampicillin at 37°C overnight. Cultures were induced with 1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) for 4 hours and duplicate samples collected each hour. The cells were harvested by centrifugation at 11800 x g and pellets were resuspended to equivalent density in phosphate buffered saline [PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4 (pH 7.4)]. Proteins were denatured in 2X loading buffer and resolved by 12% SDS-PAGE before being transferred onto nitrocellulose membrane for Western blotting using Anti-His6 (2) antibodies. Detection was performed using the BM Chemiluminescence Western Blotting Kit (Roche, Mannheim, Germany) according to the manufacturer's instructions. Proteins were visualised using the ChemiDoc Molecular Imager XRS + (Bio-Rad, USA), and images were analysed using the Image Lab TM software, version 5.1.
Purification of VP1 (1-112)
An 80 ml overnight culture transformed with pCRTVP1 was induced and cells harvested by centrifugation at 6000 x g. Prior to sonication for 1 min on ice, the pellets were resuspended in ice cold 1xLEW buffer [50 mM Na2PO4, 300 mM NaCl, (pH 8.0)] supplemented with 30 mM imidazole and 7.5% N-Lauroylsarcosine (sarcosyl). Samples were clarified by centrifugation to obtain the supernatants which were pooled and purified using Protino Ni-IDA packed columns (Machery-Nagel). The peptide was eluted with 1xElution buffer [50 mM Na2PO4, 300 mM NaCl, 250 mM imidazole, (pH 8.0)]. The protein concentrations of eluted fractions were determined by Bradford's assay. Purified protein was concentrated in VIVASPIN 4 columns (Satorius Stedim Biotech, South Africa). A total of 1.2 mg purified TMEV VP1 (1-112) was used for rabbit immunisation.
Antibodies
Anti-His6 (2) (1:3000) recognising the 6x histidine tag on pQE80-L were purchased from Roche (Mannheim, Germany). Polyclonal antibodies against TMEV VP1 (1-112) were generated in rabbits by D. Bellstedt (University of Stellenbosch, South Africa). Rabbit antibodies against TMEV GDVII non-structural protein 2C were used at a concentration 1:1000 for indirect immunofluorescence (Jauka et al., 2010) . Antibodies recognising Hsp90α and β isoforms (SC-13119) were from Santa Cruz Biotech, Santa Cruz, USA and used at 1:100.
Cells, viruses and infections
BHK-21 cells (kindly provided by M. Ryan, University of St Andrews, UK) were cultured in buffered Dulbecco's modified Eagle Medium (DMEM, Lonza Group Ltd, Basel, Switzerland) supplemented with 10% heat-inactivated foetal calf serum, 100 U penicillin ml −1 , 10 mg streptomycin ml −1 and 25 μg fungizone ml −1 at 37°C with 10% CO2. TMEV strain GDVII was used to infect cells in all experiments. Virus stocks were prepared and titred using BHK-21 cells as described previously (Murray et al., 2009 
Preparation of infected cell lysate for Western blot
For the Western blot of infected lysates, cells were collected by centrifugation at 1000 x g and resuspended in 200 µl PBS. Total proteins were denatured and resolved by 12% SDS-PAGE before transfer onto nitrocellulose membrane for Western blotting using anti-TMEV VP1 antibodies. The BM Chemiluminescence Western Blotting kit (Roche, Mannheim, Germany) was used to detect viral protein according to manufacturers' instructions.
Indirect immunofluorescence and confocal microscopy
Cells grown on sterile 13 mm glass coverslips to 100% confluency in six-well plates containing complete medium were washed twice with serum-free DMEM before the addition of 1 ml of TMEV GDVII virus stock and 1 ml serum-free DMEM. Following incubation for 1 hour at 25 ̊ C, cells were rinsed with PBS and 5 ml DMEM was added. The cells were incubated at 37º C, and lysates were prepared at 5 hours post infection (hpi). Control cells were mock-infected with serum-free DMEM. At 5 hpi, cells were collected by trypsinisation and washed with PBS before fixation with 4% paraformaldehyde for 20 min at room temperature (RT). For staining, cells were permeabilised in PB (10% sucrose, 1% Triton X-100 in PBS), blocked in PB containing 2% BSA for 30 min at RT and incubated with primary antibodies for 1 hour with shaking. Cells were washed with PBS containing 0.1% Tween-20, and incubated with species-specific Alexa Fluor 488-conjugated and/or Alexa Fluor 546-conjugated secondary antibodies for 30 min, followed by three washes. To stain the nucleus, 4',6-diamino-2-phenylindole dihydrochloride (DAPI, Sigma, St Louis, USA) was added at a concentration of 0.8 μg/ml in the second wash step. Cells were mounted using Dakofluorescence mounting medium (Dako Inc, CA, USA) and stored at RT. The helium/neon and argon lasers at wavelengths 405, 488 and 543 nm were used to excite DAPI, Alexa-fluor 488 and Alexa-fluor 546 respectively. Images were captured using the Zeiss LSM 510-Meta laser scanning confocal microscope and analysed using Zen software (blue edition, Zeiss, Germany). In order to acquire a representative image for each experiment, over 100 cells were viewed at 63 x magnification. Colocalisation analysis was performed on five randomly selected cells. Immunofluorescence experiments were performed in triplicate.
Results
Homology modelling of the TMEV GDVII protomer complex
The TMEV GDVII VP1 protein exists in complex with 3 other heterogenic subunits VP2-VP4. To distinguish predicted VP1 epitopes which remain exposed in the protomer complex from those which reside in an inter-subunit interface the 3D structure of the full TMEV GDVII protomer was calculated based on the known structures of homologous viral protomers (supplementary table S2 ). Initially ten crystal structures of homologous protomer structures were identified as possible templates (supplementary table S1). As explained in the Methodology section, out of ten two structures were chosen as final templates for model building (supplementary table S2 ). The structure 1TME was selected as a result of its high sequence identity to the GDVII protomer. The second structure 4WM8 was selected due to its higher resolution and was to be used in combination with 1TME in an attempt to improve model quality.
A primary aim of the study was to predict epitope regions within the VP1 subunit. Therefore, irrespective of the low sequence identity of 4WM8 to the full GDVII protomer, the template was still used as the VP1 subunits were 50% identical to each with the interface residues conserved. We constructed two different sets of models based on i) the lower resolution but high sequence identity template 1TME and ii) a combination of 1TME with a higher resolution template 4WM8. It must be noted that 1TME and 4WM8 were in the same conformation. The initial evaluation of the normalised DOPE-Z scores revealed a substantial increase in the quality of the models generated by a combination of 1TME and 4WM8 (supplementary table S3 ). For additional validation, the top three models of the GDVII protomer from each set were submitted to PIC for the prediction of interacting interface residues. The interacting residues were mapped to MSAs of the respective subunits of the six GDVII models. The MSAs also included the template sequences of 1TME and 4WM8. The interacting residues within all subunit-subunit interfaces predicted for both sets of GDVII models were completely conserved in the alignments. An example of this validation is shown in supplementary Fig. S2 . The structural investigation of the models using PyMOL revealed no obvious geometric discrepancies. Since there was no improvement in the interface residues based on the use of the single but higher identity template 1TME, the best scoring model was selected based on the combination of 1TME and 4WM8 for epitope prediction.
The program PROSA was used to further investigate the overall quality of the selected model. As shown in supplementary Fig. S3 , the z-scores of each subunit chain are comparable with all experimentally determined chains in the current PDB. PROSA was also used to investigate the local model quality, by plotting average residue energy scores over each 40-residue fragment in each subunit (supplementary Fig. S4 ). The low occurrence of positive values indicates high model quality, with very few problematic regions.
Prediction of linear epitope regions on the surface of TMEV GDVII VP1
Linear B-cell epitope regions within TMEV GDVII VP1 were predicted using the webservers ElliPro and BepiPred. ElliPro incorporates the Thornton method (Thornton et al., 1986) for the prediction of epitopes on the surface of a protein structure. As shown in Fig To structurally determine the surface accessibility of the overlapping epitopes in the Nterminal region ranging from the residues 1-105, the predicted epitopes were mapped into the GDVII protomer in PyMOL (Fig. 3) . The structural mapping indicated that all five epitopes are surface exposed in the protomer complex. The protomers assemble to form pentamer structures and later a full capsid, where the protomer has an external and internal capsid face.
The horizontal rotation of the protomer showed in Figs. 3A and 3B, revealed the location of 3 epitopes which reside externally and 2 epitopes on the internal face of the complex.
Antibodies have been reported to also bind to the internal region of VP1 exposed during capsid breathing in Poliovirus 1 and Parechovirus 1 (Kalynych et al., 2015) .
It was therefore hypothesised that generating polyclonal antibodies against a peptide spanning the full VP1 (1-105) region, would result in antibodies which would recognise the VP1 protein and in the assembled capsid. After the consideration of primer design, the region VP1 (1-112) was selected for expression, purification and antibody production.
VP1 (1-112) is expressed as a soluble peptide in the presence of sarcosyl
JM109 E. coli cultures harbouring pCRTVP1 and pQE-80L were grown to mid-log phase and induced with 1mM IPTG for 4 hours, in order to analyse the expression of VP1 (1-112). An over expressed peptide of approximately 19 kDa was detectable at 1 hour post-induction, and increased in intensity with time reaching a maximum at around 3 hours (Fig. 4A) . The peptide was not evident at the start of the induction or in lysate from cells harbouring the empty pQE-80L vector (Fig. 4A ). Western blot using anti-His6 antibodies confirmed that the peptide was recombinant VP1 (1-112) (Fig. 4B ).
To produce enough recombinant VP1 (1-112) for immunisation purposes, an 80ml culture of transformed E.coli JM109 cells, harbouring pCRTVP1 was induced with IPTG for 4 hours, divided into 2x40ml and cells were harvested through centrifugation. The cells were resuspended in 1XLEW [50 mM Na2PO4, 300 mM NaCl, (pH 8.0)] buffer supplemented with 30 mM imidazole and sonicated either in the absence or in the presence of 7.5% sarcosyl (data not shown). In the absence of sarcosyl, a significant amount of the peptide was found in the pellet. The addition of 7.5% sarcosyl increased the solubility of the peptide, with only small traces in the pellet and the majority of the peptide present in the soluble fraction (data not shown).
Anti-TMEV VP1 (1-112) antibodies recognise full length VP1 in infected cell lysates
To determine whether the resultant polyclonal anti-VP1 ( (Fig. 5) . No protein bands were detected in mock-infected cell lysate, indicating that the signal detected in infected lysates was a result of TMEV infection. Preimmune serum was not able to detect the 19 kDa or 37 kDa bands in bacterial or infected cell lysates (data not shown).
TMEV VP1 distributes in the cytoplasm and perinuclear region but not in the nucleus of infected cells
To examine the distribution of VP1 in TMEV-infected cells, BHK-21 cells were infected or mock-infected with TMEV, fixed with paraformaldehyde at 5 hpi, and immunostained with anti-TMEV VP1 and 2C antibodies. No signal was observed in either mock-infected cells ( Fig. 6A panel a) or in infected cells stained with secondary antibodies alone (Fig. 6A panel   b ). To confirm that cells were TMEV infected and to compare VP1 distribution, previously generated anti-TMEV 2C antibodies (Jauka et al., 2010) were used ( Fig. 6A panel c) . The 2C signal appears dominant in the perinuclear region as previously reported (Jauka et al., 2010; Mutsvunguma et al., 2011) . Following the optimisation of anti-TMEV VP1 (1-112) antibodies using different dilutions (data not shown), the VP1 signal was diffusely cytoplasmic and in the perinuclear region but absent from the nucleus of infected cells at 5 hpi ( Fig. 6A panel d) . Importantly, all infected cells observed at this time point in three separate experiments showed the same cytoplasmic distribution pattern for VP1. Following analysis of the TMEV VP1 sequence, no typical NLS was observed. Likewise, the programs used did not detect a NLS in the VP1 sequences of CVB3, EV71 or FMDV. A multiple alignment of C-terminal VP1 regions of TMEV, FMDV, EV71 and CVB3 shown in Fig. 6B showed that the basic histidine residue at position 220, suggested to be responsible for nuclear localisation of CBV3, was replaced by threonine in EV71 VP1, glycine in TMEV VP1 and valine in FMDV.
TMEV VP1 colocalises with Hsp90 at 5 hours post infection
To examine the sub-cellular distribution of VP1 in relation to Hsp90 during infection, cells grown on coverslips were infected with TMEV, fixed with paraformaldehyde at 5 hpi and costained with Hsp90 and anti-TMEV VP1 (1-112) antibodies. No signal for VP1 was observed in mock-infected cells probed with anti-TMEV VP1 antibodies (Fig. 7A) . The distribution of Hsp90 in mock-infected cells was diffuse and cytoplasmic ( Fig. 7A panel a) but changed at 5 hpi becoming more intense in the perinuclear region ( Fig. 7B panel d) . Interestingly, the signals for TMEV VP1 and Hsp90 colocalised extensively in the cytoplasm and perinuclear region (displayed by white pixels in Fig. 7B panel f) . Moreover, the frequency scatter plots indicate a high degree of colocalisation between the two signals ( Fig. 7B panel g ). The profile taken along a section of the TMEV infected cell (Fig. 7 panel h) shows that the green (VP1) and red (Hsp90) signal intensities correlate with each other throughout the cell with increased intensity in the perinuclear region compared to the cytoplasm. In comparison, Hsp90 and 2C signal was largely perinuclear and colocalised in this region (Fig. 7C panels i-k) . The frequency scatterplot confirmed colocalisation (Fig. 7C panel l ) and the profile clearly shows that red (Hsp90) and green (2C) signal intensities were less correlated in the cytoplasm than in the case of VP1, and increased asymmetrically in the perinuclear region (Fig. 7 panel m) .
The above analysis was performed on five randomly selected cells co-stained with anti-VP1/anti-2C and Hsp90 antibodies.
Discussion
The primary aim of this study was to generate antibodies against the TMEV GDVII VP1
protein subunit and test their specificity in detecting VP1 in infected cells by Western blotting and indirect immunofluorescence. To date, very few studies describe the localisation of picornavirus capsid subunits in cells at early stages of virus assembly which remains a poorly understood process in the virus life cycle. There is substantial evidence to suggest that picornavirus replication and assembly take place on the surface of specialised membrane vesicles and that the viral proteins associate with these membranes (Bienz et al., 1983; Egger et al., 2002; Jackson et al., 2005; Schwartz et al., 2004 ) thereby complicating their solubilisation and purification in a heterologous system for downstream applications. Indeed, previous attempts to solubilise and purify the full-length TMEV VP1 protein were unsuccessful. To address this problem, a bioinformatics approach was used to map a region on VP1 predicted to contain surface-exposed linear B-cell epitopes, and which could be purified in a soluble form for immunisation purposes. Because VP1 exists as part of a protomer complex within the viral capsid, homology modelling was used to generate a 3D structure of the TMEV protomer complex to accurately predict and assess the surface accessibility of linear epitopes on the protein. Furthermore, since VP1 is an antigenic determinant of the capsid, it was reasonable to assume that antibodies generated against an immunogenic VP1 peptide would also recognise the full-length protein as well as viral capsids in infected cells. Following a bioinformatics analysis of VP1, the N-terminal region (amino acids 1-112) was predicted to contain surface linear B-cell epitopes at amino acid positions 1-18, 24-30, 50-56, 78-88, 98-105 , and was selected for bacterial expression and purification. The antibodies were able to detect the bacterially expressed VP1 peptide (1-112)
as expected, but were also specific in detecting full length VP1 protein in TMEV-infected cells lysates with no contaminating proteins. Because lysates were not fractionated in these experiments, it cannot be concluded that TMEV VP1 is present predominantly in a membrane-associated or soluble form. It is surprising that the P1 precursor protein was not detected in infected cell lysates using anti-TMEV VP1 antibodies. This observation will be further investigated and if found to be valid, indicates that these antibodies are an extremely useful tool in investigating the localisation and interactions of VP1 with host components during virus assembly.
To (Bhuvanakantham et al., 2010) , porcine reproductive and respiratory syndrome virus (PRRSV) (Pei et al., 2009) , Dengue virus (Colpitts et al., 2011) and the picornavirus CVB3 four viral proteins. However, previous analysis of the CVB3 VP1 sequence showed that, although the protein did not display a typical NLS, a C-terminal histidine residue at position 220 (H220) was a critical determinant required for active translocation to the nucleus . To investigate whether this residue is present in TMEV and other related viruses, a multiple sequence alignment between VP1 C-terminal sequences of several picornaviruses was performed. The H220 in CVB3 was substituted for threonine in EV71
VP1 which has been shown to distribute in the cytoplasm of infected cells Wang et al., 2012) . The lack of a typical NLS and observation that H220 is replaced by glycine in TMEV VP1 provides an explanation for the similar cytoplasmic distributions of EV71 and TMEV VP1 proteins. Similarly in FMDV VP1, the H220 residue is replaced by valine. Interestingly, the distribution of TMEV VP1 at 5 hpi was not unlike that of FMDV during late infection where VP1 localised predominantly to the perinuclear region of FMDV infected cells and colocalised with the replication protein 2C (Knox et al., 2005) .
Hsp90 has vital functions in the cell including protein folding and trafficking, maintenance of protein stability and regulation of cell growth and differentiation (Passinen et al., 2001; Picard, 2004; Pratt and Toft, 2013; Zhang et al., 2013) . Hsp90 is upregulated under conditions of stress, including viral infection, and is required for the replication and capsid assembly of many viruses, including picornaviruses such as PV and HRV (Geller et al., 2012) . that Hsp90 and VP1 colocalise suggest that Hsp90 is required during the early stages of TMEV capsid assembly. These results support existing evidence that Hsp90 is involved in the picornavirus capsid assembly but may not be directly involved with virus replication (Geller et al., 2007) .
In conclusion, this is the first study to report the distribution of TMEV VP1 in infected cells by Western blot and indirect immunofluorescence. Significantly, VP1 signal distribution was found to be cytoplasmic with greater signal intensity in the perinuclear region. This coupled with its absence from the nucleus and the lack of a typical NLS indicate that TMEV VP1 behaves in a similar manner to that of picornaviruses such as FMDV and Enterovirus 71.
Overlap between VP1 and Hsp90 distribution supports the previous observation that Hsp90 plays an important role for this chaperone in the TMEV life cycle (Mutsvunguma et al., 2011) . The generation of TMEV VP1 specific polyclonal antibodies and their optimisation by Western blot and indirect immunofluorescence is an important milestone that has provided the tool and methodologies necessary for future studies investigating interactions between this capsid subunit and host cell factors to better understand not only the process of capsid assembly but also the mechanisms involved in the early stages of picornavirus entry.
Populus Hsp90 capsid proteins form the capsomer, of which 5 combine to produce the pentamer. 12 pentamers then associate around the mRNA genome to generate the provirion. VP0 is then cleaved yielding the outer facing VP2 capsid protein and the internally oriented VP4 protein, maturing the newly formed virion. Alternatively 12 pentamers can assemble without inclusion of the mRNA genome to yield empty 80S procapsids. Purified pentamers are able to assemble into empty procapsids in a cell free test tube environment through "selfassembly", indicating that assembly from pentamer to capsid maturation is based on proteinprotein interactions (Li et al., 2012) . However the stages from P1 precursor cleavage to pentamer formation remain enigmatic, and seem to require both viral and host cell factors.
Adapted from Jiang et al. (2014) . Theiler's Virus (1TME) and Enterovirus D68 (4WM8), was generated using MODELLER.
The model has been coloured by subunit: green -VP1; cyan -VP2; pink -VP3; yellow -VP4; orange -amino acid regions predicted to map to linear B-cell epitopes as predicted by 
